194 related articles for article (PubMed ID: 20229566)
41. Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.
Glória PM; Coutinho I; Gonçalves LM; Baptista C; Soares J; Newton AS; Moreira R; Saraiva L; Santos MM
Eur J Med Chem; 2011 Jun; 46(6):2141-6. PubMed ID: 21439692
[TBL] [Abstract][Full Text] [Related]
42. Blockade of the NLRP3/caspase-1 axis attenuates ketamine-induced hippocampus pyroptosis and cognitive impairment in neonatal rats.
Zhang Z; Bai H; Ma X; Shen M; Li R; Qiu D; Li S; Gao L
J Neuroinflammation; 2021 Oct; 18(1):239. PubMed ID: 34666787
[TBL] [Abstract][Full Text] [Related]
43. Fluorescent nitrile-based inhibitors of cysteine cathepsins.
Frizler M; Mertens MD; Gütschow M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7715-8. PubMed ID: 23122525
[TBL] [Abstract][Full Text] [Related]
44. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.
Wieczerzak E; Drabik P; Łankiewicz L; Ołdziej S; Grzonka Z; Abrahamson M; Grubb A; Brömme D
J Med Chem; 2002 Sep; 45(19):4202-11. PubMed ID: 12213061
[TBL] [Abstract][Full Text] [Related]
45. Molecular dynamics-assisted pharmacophore modeling of caspase-3-isatin sulfonamide complex: Recognizing essential intermolecular contacts and features of sulfonamide inhibitor class for caspase-3 binding.
Kumar SP; Patel CN; Jha PC; Pandya HA
Comput Biol Chem; 2017 Dec; 71():117-128. PubMed ID: 29153890
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
[TBL] [Abstract][Full Text] [Related]
47. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
[TBL] [Abstract][Full Text] [Related]
49. Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties.
Richter HG; Benson GM; Bleicher KH; Blum D; Chaput E; Clemann N; Feng S; Gardes C; Grether U; Hartman P; Kuhn B; Martin RE; Plancher JM; Rudolph MG; Schuler F; Taylor S
Bioorg Med Chem Lett; 2011 Feb; 21(4):1134-40. PubMed ID: 21269824
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in the synthesis, design and selection of cysteine protease inhibitors.
Hernandez AA; Roush WR
Curr Opin Chem Biol; 2002 Aug; 6(4):459-65. PubMed ID: 12133721
[TBL] [Abstract][Full Text] [Related]
51. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
[TBL] [Abstract][Full Text] [Related]
52. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
53. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model.
Flores J; Noël A; Foveau B; Lynham J; Lecrux C; LeBlanc AC
Nat Commun; 2018 Sep; 9(1):3916. PubMed ID: 30254377
[TBL] [Abstract][Full Text] [Related]
54. Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Rankovic Z; Cai J; Kerr J; Fradera X; Robinson J; Mistry A; Hamilton E; McGarry G; Andrews F; Caulfield W; Cumming I; Dempster M; Waller J; Scullion P; Martin I; Mitchell A; Long C; Baugh M; Westwood P; Kinghorn E; Bruin J; Hamilton W; Uitdehaag J; van Zeeland M; Potin D; Saniere L; Fouquet A; Chevallier F; Deronzier H; Dorleans C; Nicolai E
Bioorg Med Chem Lett; 2010 Mar; 20(5):1524-7. PubMed ID: 20149657
[TBL] [Abstract][Full Text] [Related]
55. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
Wen S; Deng F; Li L; Xu L; Li X; Fan Q
J Diabetes Investig; 2022 Jan; 13(1):22-33. PubMed ID: 34494385
[TBL] [Abstract][Full Text] [Related]
56. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
Löser R; Frizler M; Schilling K; Gütschow M
Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
[No Abstract] [Full Text] [Related]
57. Non-peptidic inhibitors of cysteine proteases.
Schirmeister T; Kaeppler U
Mini Rev Med Chem; 2003 Jun; 3(4):361-73. PubMed ID: 12678829
[TBL] [Abstract][Full Text] [Related]
58. NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl
Clauzure M; Valdivieso ÁG; Dugour AV; Mori C; Massip-Copiz MM; Aguilar MÁ; Sotomayor V; Asensio CJA; Figueroa JM; Santa-Coloma TA
Immunology; 2021 Aug; 163(4):493-511. PubMed ID: 33835494
[TBL] [Abstract][Full Text] [Related]
59. Ensemble-based ADME-Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE.
Scala A; Rescifina A; Micale N; Piperno A; Schirmeister T; Maes L; Grassi G
Chem Biol Drug Des; 2018 Feb; 91(2):597-604. PubMed ID: 29045053
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications.
Ullman BR; Aja T; Deckwerth TL; Diaz JL; Herrmann J; Kalish VJ; Karanewsky DS; Meduna SP; Nalley K; Robinson ED; Roggo SP; Sayers RO; Schmitz A; Ternansky RJ; Tomaselli KJ; Wu JC
Bioorg Med Chem Lett; 2003 Oct; 13(20):3623-6. PubMed ID: 14505683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
